Group 1 - The company has confirmed that all its constructed projects have production capabilities [2] - The specific product, Ammonium Chloride Dimethyl Benzamide, has not yet commenced production, while other intermediates and raw drug projects are already in production [2]

Group 1 - The core point of the article is that Hongyang (000525) has confirmed that all its established projects are operational, with the exception of the production of ammonium chlorodimethylbenzamide, which has not yet commenced [1] - The company has successfully launched production for other intermediates and active pharmaceutical ingredient projects [1]